Cancer Medicines Forum workshop
April 5
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.
The CMF will report its observations and preliminary solutions to address treatment optimisation at a hybrid workshop at the EMA under the Auspices of the EU Belgian Presidency.
Date: Friday, 5 April 2024, 1:00-6:00 PM (CEST)
Location: European Medicines Agency, Amsterdam
Registration will close on 1 March 2024 for in-person participation and will remain open until 29 March 2024 for online participation.
Next events
EORTC Melanoma Group Autumn Meeting 2024
September 11 - September 12
Barcelona, Spain
CDDF-EORTC Workshop on Innovation and Access in Rare Cancers
September 23 - September 24
Amsterdam, NL (Hybrid Event)
EORTC Quality of Life Group Autumn Meeting 2024
September 26 - September 27
Innsbruck, Austria
EORTC Pathobiology Group Autumn Meeting 2024
October 2
Virtual Event
EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 2024
October 9 - October 11
Lausanne, Switzerland
